Breast Imaging Market, by Technology (Ionizing Breast Imaging Technology (Analog Mammography, Full Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Positron Emission Tomography/ Computed Tomography (PET/CT), Molecular Breast Imaging/ Breast Spec

Breast Imaging Market, by Technology (Ionizing Breast Imaging Technology (Analog Mammography, Full Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Positron Emission Tomography/ Computed Tomography (PET/CT), Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI), Positron Emission Mammography, Others), Non-Ionizing Breast Imaging Technology (Breast MRI (Magnetic Resonance Imaging), Breast Ultrasound, Optical Imaging, Automated Whole Breast Ultrasound (AWBU), Breast Thermography)), by End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

The breast consists of glands called lobules that are capable of producing milk. This milk is carried through thin tubes called ducts to the lobules or the nipples. The breast tissue also contains fat and connective tissue as well as blood vessels and lymph nodes. Thus breast imaging is the technique that is used to examine the breast by providing the detailed representation of it on computer for lumps or changes in size or shape. Hence, this technique aids in the early detection and diagnosis of breast cancer.

Market Dynamics

Upsurge in prevalence of breast cancer is anticipated to fuel growth of the breast imaging market. Breast cancer can occur both in men and women. It is majorly reported in females as compared to men. According to the National Cancer Institute coordinates the U.S. National Cancer Program and is part of the National Institutes of Health stated that around 100 times more new cases of breast cancer were reported in women than in men annually.

Furthermore, according to the American Cancer Society in the US in 2021, there were estimated 2.8 thousand cases of invasive breast cancer diagnosed and 2,650 cases were diagnosed in men and an additional 49,290 cases of ductal carcinoma in situ (DCIS) diagnosed in women.

Moreover, supportive awareness initiatives by Non-governmental organizations will help in spreading awareness about the risk factors, preventive measures, and early diagnosis of breast cancer. For instance, On April 02, 2022, a special breast cancer awareness campaign “Jeeto” was launched by various organization in Punjab, India. As part of the initiative, awareness seminars will be conducted at educational institutes and educational pamphlets will be distributed.

Key features of the study:

• This report provides an in-depth analysis of the global breast imaging market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global breast imaging market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Hologic, Inc., General Electric Company, Siemens AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global breast imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global breast imaging market

Detailed Segmentation:

• Global Breast imaging Market, By Technology:
• Ionizing Breast Imaging Technology
• Analog Mammography
• Full Field Digital Mammography (FFDM)
• 3D Breast Tomosynthesis
• Positron Emission Tomography/ Computed Tomography (PET/CT)
• Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
• Positron Emission Mammography
• Others
• Non-Ionizing Breast Imaging Technology
• Breast MRI (Magnetic Resonance Imaging)
• Breast Ultrasound
• Optical Imaging
• Automated Whole Breast Ultrasound (AWBU)
• Breast Thermography
• Global Breast imaging Market, By End User:
• Hospitals
• Diagnostic Laboratories
• Ambulatory Surgical Center
• Global Breast imaging Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Hologic, Inc. *
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• General Electric Company
• Siemens AG
• Koninklijke Philips N.V.
• Fujifilm Holdings Corporation
• Gamma Medica, Inc.
• Toshiba Corporation
• Sonocine, Inc.
• Aurora Imaging Technology, Inc.
• Dilon Technologies, Inc.

“*” marked represents similar segmentation in other categories in the respective section.